Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mimetogen Pharmaceuticals

Mimetogen Pharmaceuticals?uq=UG6efJS6
2005 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$800K LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of uses for peptidomimetics designed to be a novel approach for treating ophthalmic diseases. The company focuses on treating dry eye, glaucoma, keratoconus, and retinitis pigmentosa, providing patients with options for treating eye diseases that to date have only limited or no treatment or cure.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1000 de La Gauchetiere Street West
  • Suite 900
  • Montreal, Quebec H3B 5H4
  • Canada

+1 (514) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mimetogen Pharmaceuticals’s full profile, request a free trial.

Mimetogen Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 18-Jul-2013 $800K 00.000 Completed Startup
3. Later Stage VC (Series B) 25-Feb-2011 00000 Completed Startup
2. Early Stage VC (Series A) 07-Oct-2009 $848K Completed Startup
1. Seed Round 31-Oct-2005 $848K $848K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Mimetogen Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Schooner Capital Growth/Expansion Minority 000 0000 000000 0
Medwell Capital Other Minority 000 0000 000000 0
MSBi Valorisation Venture Capital Minority 000 0000 000000 0
VIMAC Ventures Venture Capital Minority 000 0000 000000 0
inovia Capital Venture Capital Minority 000 0000 000000 0

Mimetogen Pharmaceuticals Executive Team (11)

Name Title Board
Seat
Contact
Info
Francois Mongrain Vice President of Finance & Chief Financial Officer
Karen Meerovitch Ph.D Senior Director of Clinical Development
Stephen Pflugfelder MD Advisor
Edward Holland MD Advisor
Eric Donnenfeld Advisor

4 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

Mimetogen Pharmaceuticals Board Members (5)

Name Representing Role Since Contact
Info
C├ędric Bisson MD Self Board Member 000 0000
Martin Wax MD Self Chairman 000 0000
Sena Biswas Ph.D VIMAC Ventures Board Member 000 0000

2 Former Board Members

You’re viewing 3 of 5 board members. Get the full list »